{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:06:11Z","timestamp":1769594771735,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/igc.0b013e318257b936","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T12:11:07Z","timestamp":1340799067000},"page":"974-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of Risk-Reducing Salpingo-Oophorectomy in Preventing Ovarian Cancer in a High-Risk French Canadian Population"],"prefix":"10.1016","volume":"22","author":[{"given":"Omar Moreira","family":"Bacha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Grondin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"Edelweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Laframboise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318257b936_bb0005","series-title":"Canadian Cancer Statistics 2010","author":"Canadian Cancer Society\u2019s Steering Committee","year":"2010"},{"key":"10.1097\/IGC.0b013e318257b936_bb0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","article-title":"A systematic genetic assessment of 1433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes","volume":"81","author":"Easton","year":"2007","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e318257b936_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"113","author":"ACOG Practice Bulletin","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0020","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based casecontrol study","volume":"95","author":"Rutter","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318257b936_bb0025","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e318257b936_bb0035","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318257b936_bb0040","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318257b936_bb0045","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-med-010910-110221","article-title":"Therapeutic approaches for women predisposed to breast cancer","volume":"62","author":"Nathanson","year":"2011","journal-title":"Annu Rev Med."},{"key":"10.1097\/IGC.0b013e318257b936_bb0050","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/dji281","article-title":"Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families","volume":"97","author":"Kauff","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318257b936_bb0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cdp.2004.03.003","article-title":"Bilateral oophorectomy and breast risk reduction among women with a family history","volume":"28","author":"Olsen","year":"2004","journal-title":"Cancer Detect Prev."},{"key":"10.1097\/IGC.0b013e318257b936_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","article-title":"Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer","volume":"44","author":"Simard","year":"2007","journal-title":"J Med Genet."},{"key":"10.1097\/IGC.0b013e318257b936_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318257b936_bb0070","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist\u2019s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0085","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318257b936_bb0095","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318257b936_bb0100","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0105","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am JHum Genet."},{"key":"10.1097\/IGC.0b013e318257b936_bb0115","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318257b936_bb0120","first-page":"231","article-title":"Clinical management guidelines for obstetrician-gynecologists","volume":"111","author":"ACOG Practice Bulletin","year":"2008","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.37984.623889.F6","article-title":"The eVALuate Study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal surgery","volume":"328","author":"Garry","year":"2004","journal-title":"BMJ."},{"key":"10.1097\/IGC.0b013e318257b936_bb0135","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1525-1438.2007.01128.x","article-title":"Possible association between BRCA-1 carriers and incidence of uterine papillary serous carcinoma (UPSC)","volume":"18","author":"Lavie","year":"2008","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318257b936_bb0140","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e318257b936_bb0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3109\/01443615.2010.492433","article-title":"ATAC Trialists\u2019 Group. The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol","volume":"30","author":"Duffy","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"10.1097\/IGC.0b013e318257b936_bb0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA Mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24021765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24021765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e318257b936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:01:58Z","timestamp":1753228918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24021765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1048891X24021765"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318257b936","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Risk-Reducing Salpingo-Oophorectomy in Preventing Ovarian Cancer in a High-Risk French Canadian Population","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318257b936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}